These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28395806)

  • 1. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
    Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
    Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
    Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
    Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
    Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring.
    Wongkummool W; Maneepitasut W; Munkongdee T; Tong-Ngam P; Tangprasittipap A; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():84-87. PubMed ID: 28395746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human iPSCs from urine derived cells of a non-affected control subject.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
    Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
    Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
    Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
    Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
    Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
    Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
    Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
    Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
    Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of HEXA-deficient hiPSCs from fibroblasts of a Tay-Sachs disease patient.
    Liu Z; Zhao R
    Stem Cell Res; 2016 Sep; 17(2):289-291. PubMed ID: 27879213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
    Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2017 Jan; 18():41-44. PubMed ID: 28395801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
    Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2.
    Wongkummool W; Maneepitasut W; Tong-Ngam P; Tangprasittipap A; Munkongdee T; Boonchuay C; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():80-83. PubMed ID: 28395745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
    Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.